Literature DB >> 21411969

The bidirectional crosstalk between human dendritic cells and natural killer cells.

Rebekka Wehner1, Kristin Dietze, Michael Bachmann, Marc Schmitz.   

Abstract

Dendritic cells (DCs) are professional antigen-presenting cells, which display an extraordinary capacity to induce T-cell responses. Recent findings revealed that DCs also play a crucial role in the activation of natural killer (NK) cells representing important effectors in the innate immune defense against viruses and tumors. Here, we summarize various studies investigating the bidirectional crosstalk between human DCs and NK cells. In this context, it has been reported that DCs efficiently enhance CD69 expression, proliferation, interferon (IFN)-γ secretion and cytotoxic activity of NK cells. Cell membrane-associated molecules as well as soluble factors such as interleukin-12, tumor necrosis factor-α and type I IFNs contributed to DC-mediated NK cell activation. Reciprocally, the ability of human NK cells to enhance the immunostimulatory capacity of DCs was shown. Thus, NK cells promoted the maturation of DCs and markedly augmented their capacity to produce proinflammatory cytokines and to stimulate T-cell responses. The NK cell-mediated effects on DCs were dependent on cell membrane-associated molecules such as NKp30 and soluble factors such as tumor necrosis factor-α and IFN-γ. In conclusion, the reciprocal activating interaction between human DCs and NK cells may play a pivotal role in the immune defense against viruses and tumors.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411969     DOI: 10.1159/000323923

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  50 in total

1.  Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds.

Authors:  Flavia Fontana; Raquél Bartolo; Hélder A Santos
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.

Authors:  Julia Herrmann; Hannah Berberich; Jessica Hartmann; Steffen Beyer; Karen Davies; Joachim Koch
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

Review 3.  Genome-wide association studies in Sjögren's syndrome: What do the genes tell us about disease pathogenesis?

Authors:  Peter D Burbelo; Kiran Ambatipudi; Ilias Alevizos
Journal:  Autoimmun Rev       Date:  2014-03-18       Impact factor: 9.754

4.  The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding.

Authors:  Jessica Hartmann; Thuy-Van Tran; Janina Kaudeer; Karin Oberle; Julia Herrmann; Isabell Quagliano; Tobias Abel; André Cohnen; Volker Gatterdam; Andrea Jacobs; Bernd Wollscheid; Robert Tampé; Carsten Watzl; Andreas Diefenbach; Joachim Koch
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

Review 5.  Liaison between natural killer cells and dendritic cells in human gestation.

Authors:  Ester Leno-Durán; Raquel Muñoz-Fernández; Enrique García Olivares; Irene Tirado-González
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

6.  IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.

Authors:  Malte Bachmann; Patrick Scheiermann; Lorena Härdle; Josef Pfeilschifter; Heiko Mühl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

7.  The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Authors:  Stephanie M Dillon; Eric J Lee; Julia M Bramante; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

8.  Shaping of NK cell responses by the tumor microenvironment.

Authors:  Ana Stojanovic; Margareta P Correia; Adelheid Cerwenka
Journal:  Cancer Microenviron       Date:  2012-12-16

9.  Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis.

Authors:  Marieta Toma; Rebekka Wehner; Anja Kloß; Linda Hübner; Georgia Fodelianaki; Kati Erdmann; Susanne Füssel; Stefan Zastrow; Matthias Meinhardt; Barbara Seliger; Dorothee Brech; Elfriede Noessner; Torsten Tonn; Knut Schäkel; Martin Bornhäuser; Michael P Bachmann; Manfred P Wirth; Gustavo Baretton; Marc Schmitz
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

10.  Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.

Authors:  Raghvendra M Srivastava; Steve C Lee; Pedro A Andrade Filho; Christopher A Lord; Hyun-Bae Jie; H Carter Davidson; Andrés López-Albaitero; Sandra P Gibson; William E Gooding; Soldano Ferrone; Robert L Ferris
Journal:  Clin Cancer Res       Date:  2013-02-26       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.